Home NDC 0456-2700 AVYCAZ
Product NDC 0456-2700
11-digit product format 004562700
Labeler code 0456
Product ID 0456-2700_5da940bc-28c3-4e0c-ac51-912f8cc1beb1
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ceftazidime, avibactam
Dosage form POWDER, FOR SOLUTION
Route INTRAVENOUS
Labeler Allergan, Inc.
Application NDA206494
Marketing category NDA
Marketing start 2014-12-26
Substance AVIBACTAM SODIUM; CEFTAZIDIME
Active strength .5; 2 g/1; g/1
Pharmacologic classes Cephalosporin Antibacterial [EPC], Cephalosporins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N206494-001 AVYCAZ AVIBACTAM SODIUM; CEFTAZIDIME EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N206494-001 7112592 2026-01-07 U-2244 Drug substance, Drug product 2015-03-17 N206494-001 7112592 2026-01-07 U-2508 Drug substance, Drug product 2015-03-17 N206494-001 7112592 2026-01-07 U-282 Drug substance, Drug product 2015-03-17 N206494-001 7112592 2026-01-07 U-3818 Drug substance, Drug product 2015-03-17 N206494-001 7612087 2026-11-12 Drug product 2015-03-17 N206494-001 8835455 2030-10-08 Drug product 2015-03-17 N206494-001 8471025 2031-08-12 Drug substance 2015-03-17 N206494-001 8969566 2032-06-15 Drug substance 2015-03-17 N206494-001 9284314 2032-06-15 Drug substance 2017-02-24 N206494-001 9695122 2032-06-15 Drug substance 2017-08-08
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N206494-001 NPP 2027-01-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / IV (INFUSION) RLD, RS 2015-02-25 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / IV (INFUSION) RLD, RS 2015-02-25 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / IV (INFUSION) RLD, RS 2015-02-25 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / IV (INFUSION) RLD, RS 2015-02-25 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / IV (INFUSION) RLD, RS 2015-02-25 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / IV (INFUSION) RLD, RS 2015-02-25 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N206494-001 AVYCAZ EQ 0.5GM BASE;2GM/VIAL POWDER / INTRAVENOUS RLD, RS 2015-02-25 cb3db0bc1861…
Observed Orange Book patent history# Patent history page 1 of 11 · 412 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N206494-001 7112592 2026-01-07 U-2508 Drug substance, Drug product 2015-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206494-001 7112592 2026-01-07 U-2244 Drug substance, Drug product 2015-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206494-001 7112592 2026-01-07 U-282 Drug substance, Drug product 2015-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206494-001 7112592 2026-01-07 U-3818 Drug substance, Drug product 2015-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206494-001 7612087 2026-11-12 Drug product 2015-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206494-001 8835455 2030-10-08 Drug product 2015-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206494-001 8471025 2031-08-12 Drug substance 2015-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206494-001 8969566 2032-06-15 Drug substance 2015-03-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206494-001 9284314 2032-06-15 Drug substance 2017-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N206494-001 9695122 2032-06-15 Drug substance 2017-08-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 7112592 2026-01-07 U-2508 Drug substance, Drug product 2015-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 7112592 2026-01-07 U-2244 Drug substance, Drug product 2015-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 7112592 2026-01-07 U-282 Drug substance, Drug product 2015-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 7112592 2026-01-07 U-3818 Drug substance, Drug product 2015-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 7612087 2026-11-12 Drug product 2015-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 8835455 2030-10-08 Drug product 2015-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 8471025 2031-08-12 Drug substance 2015-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 8969566 2032-06-15 Drug substance 2015-03-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 9284314 2032-06-15 Drug substance 2017-02-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N206494-001 9695122 2032-06-15 Drug substance 2017-08-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N206494-001 7112592 2026-01-07 U-2508 Drug substance, Drug product 2015-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206494-001 7112592 2026-01-07 U-2244 Drug substance, Drug product 2015-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206494-001 7112592 2026-01-07 U-282 Drug substance, Drug product 2015-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206494-001 7112592 2026-01-07 U-3818 Drug substance, Drug product 2015-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206494-001 7612087 2026-11-12 Drug product 2015-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206494-001 8835455 2030-10-08 Drug product 2015-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206494-001 8471025 2031-08-12 Drug substance 2015-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206494-001 8969566 2032-06-15 Drug substance 2015-03-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206494-001 9284314 2032-06-15 Drug substance 2017-02-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N206494-001 9695122 2032-06-15 Drug substance 2017-08-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 7112592 2026-01-07 U-2508 Drug substance, Drug product 2015-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 7112592 2026-01-07 U-2244 Drug substance, Drug product 2015-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 7112592 2026-01-07 U-282 Drug substance, Drug product 2015-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 7112592 2026-01-07 U-3818 Drug substance, Drug product 2015-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 7612087 2026-11-12 Drug product 2015-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 8835455 2030-10-08 Drug product 2015-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 8471025 2031-08-12 Drug substance 2015-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 8969566 2032-06-15 Drug substance 2015-03-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 9284314 2032-06-15 Drug substance 2017-02-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N206494-001 9695122 2032-06-15 Drug substance 2017-08-08 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 102 observed states.
Additional Listing Data#
Finished product Yes
Brand name base AVYCAZ
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CEFTAZIDIME .5 g/1 AVIBACTAM SODIUM 2 g/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 9M416Z9QNR Internal UNII lookup 9V824P8TAI Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1603840 Internal RxNorm lookup 1603845 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0456-2700-01 AVYCAZ 1 in 1 VIAL, SINGLE-DOSE POWDER, FOR SOLUTION 1 24 0456-2700-10 AVYCAZ 10 in 1 CARTON POWDER, FOR SOLUTION 10 24
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded avibactam sodium ACTIVE INGREDIENT 9V824P8TAI AVYCAZ (CEFTAZIDIME, AVIBACTAM) POWDER, FOR SOLUTION [FOREST LABORATORIES, INC.] 2 ceftazidime ACTIVE INGREDIENT 9M416Z9QNR AVYCAZ (CEFTAZIDIME, AVIBACTAM) POWDER, FOR SOLUTION [FOREST LABORATORIES, INC.] 2 avibactam ACTIVE MOIETY 7352665165 AVYCAZ (CEFTAZIDIME, AVIBACTAM) POWDER, FOR SOLUTION [FOREST LABORATORIES, INC.] 2 ceftazidime anhydrous ACTIVE MOIETY DZR1ENT301 AVYCAZ (CEFTAZIDIME, AVIBACTAM) POWDER, FOR SOLUTION [FOREST LABORATORIES, INC.] 2 sodium carbonate INACTIVE INGREDIENT 45P3261C7T AVYCAZ (CEFTAZIDIME, AVIBACTAM) POWDER, FOR SOLUTION [FOREST LABORATORIES, INC.] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0456-2700 AVYCAZ (CEFTAZIDIME, AVIBACTAM) POWDER, FOR SOLUTION [ALLERGAN, INC.] 24 Current NDC, Legacy NDC, 2 package rows 20250504_d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 0456-2700-01 00456270001 1 in 1 VIAL, SINGLE-DOSE Historical 0456-2700-10 00456270010 10 VIAL, SINGLE-DOSE in 1 CARTON (0456-2700-10) / 1 POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0456-2700-01) 2014-12-26 0000-00-00 No No Current